Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Prevalence of APOL1-mediated kidney disease
9 evidence topics · 17 sources
United States: high-risk genotype frequency among Black Americans
“Based on cohort and cross-sectional studies in the United States, the estimated allelic frequency among African Americans is 20%–22% for G1 and 13%–15% for G2, with approximately 10%–15% having an APOL1 high-risk genotype.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Among Black individuals in the US, the G1 allele frequency is 22% and G2 allele frequency is 13%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Approximately 13% of Black individuals in the US (more than 5 million people) have a high-risk APOL1 genotype.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In the MVP cohort, 15,604 (12.8%) had two APOL1 HR variants, of which 582 (0.5%) also had APOL1 p.N264K.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Allele frequencies of the G1 and G2 alleles were 22% and 13%, respectively (Table 1). Overall, 13.2% of the study sample carried two APOL1 risk alleles (G1/G1, G1/G2, or G2/G2), whereas 45.4% and 41.4% carried one (wild type [WT]/G1 or WT/G2) or zero (WT/WT) risk alleles, respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
United States: estimated share of the Black population affected
“Approximately 10%–15% of the Black population has a high-risk APOL1 genotype” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“we can estimate that up to 3% of the Black population will be affected.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
West Africa and sub-Saharan Africa: high-risk genotype frequency
“Frequencies of APOL1 high-risk genotypes are highest in West Africa, with up to 50% in Southeastern Nigeria, 37% in Central Ghana, and 25% in Southwestern Nigeria (Figure 3).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Given that more than 100 million people in Sub-Saharan Africa may have 2 APOL1 high-risk alleles, the potential burden of APOL1 kidney disease in this region is catastrophically high.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The Human Health and Heredity in Africa (H3Africa) Kidney Disease Research Network studied 8,355 participants from Ghana and Nigeria: 4,712 participants with CKD stages 2–5, 866 participants with biopsy proven glomerular diseases, and 2777 controls (eGFR ≥90 ml/min/1.73m2 without proteinuria).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Overall, 43.0% and 29.7% participants carried 1 and 2 APOL1 risk variants, respectively (Table S4). The G1 haplotype was more frequent (40.7%) than the G2 haplotype (13.9%). The prevalence of APOL1 high-risk carriers was higher among persons with CKD compared to those without CKD (31.6% vs. 25.7%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In Africa, the APOL1 risk alleles are heavily concentrated in West Africa, and they are found at lower frequencies in eastern and southern Africa (15). For example, some groups within Nigeria or Ghana have combined risk variant allele frequencies that may exceed 50% (with high-risk genotypes of 25%), whereas individuals in Ethiopia, Sudan, and Somalia have very low probability of having two APOL1 risk variants.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
The Americas: high-risk genotype frequency in 111 populations
“we found elevated frequencies of the APOL1 haplotype in African-American, sub-Saharan African, and Western African populations (11 to 32%). However, we also found other populations with elevated frequencies, including Jamaican, Barbadian, Grenadian, and Brazilian from Salvador (>10 to 22%); Trinidadian, Panamanian, Honduran, Haitian, Garifunan, and Palenque (>5 to 10%); and Guyanese, Dominican, Peruvian, Belizean, and Native American (1 to 5%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Europe: high-risk genotype in unexplained kidney failure in the UK 100,000 Genomes Project
“The study recruited 218 patients with uKF onset before age 50 years from the United Kingdom's 100,000 Genomes Project.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Among individuals with recent African ancestry, high-risk APOL1 genotypes were significantly more common in those with uKF (52% vs 8.4% in those without uKF; P < 0.001).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Key areas of need include prevalence data for Black populations in the Caribbean, Brazil, the United Kingdom, Belgium, France, Sub-Saharan Africa, and any populations originating after dislocation by the diaspora (Table 1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
High-risk genotype among Black patients with nondiabetic CKD, FSGS, and hypertension-attributed ESKD
“The high-risk genotypes are found in approximately 16%–23% of Black people with nondiabetic CKD” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“40%–60% of those with primary FSGS have 2 APOL1 risk alleles.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A high-risk APOL1 genotype is present in about 75% of Black patients with FSGS (1,33).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Similarly, approximately 50% of Black patients with hypertension-attributable ESKD have a high-risk APOL1 genotype (1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
High-risk genotype among people referred for APOL1 genotyping or kidney genetic testing
“Of 15,181 patients, 1035 (6.8%) had high-risk APOL1 genotypes.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Considering APOL1 genotypes, 25.6% of patients in the genetic African ancestry cluster had high-risk APOL1 genotypes (n = 944), 39.5% were single risk allele carriers (n = 1453), and 34.8% had G0/G0 (n = 1281; Table 2 and Supplementary Figure S3).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote